300246.SZ
Guangdong Biolight Meditech Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 14.80
−1.79%Aug 21, 2026, 08:41 UTC
Baolait announced its H1 2026 results: net loss of 34.4869 million yuan, turning from a profit of 1.3134 million yuan in the same period of 2025.
Source:Aug 19, 2026, 13:49 UTC
On August 19, 2026, three A-share listed companies, including Baolait, Zhongjiao Design, and Huaxin Building Materials, disclosed plans to increase their holdings.
Source:Aug 9, 2026, 07:36 UTC
Baolait terminated the planning of a control change matter; its stock and convertible bonds resumed trading on August 10, 2026.
Source:Aug 4, 2026, 09:01 UTC
Baolait announced on August 4, 2026 that it will close or partially terminate certain fundraising investment projects and use the remaining 60.6631 million yuan to permanently supplement working capital, pending shareholder approval.
Source:Jul 23, 2026, 10:08 UTC
Baolait announced it received a medical device registration certificate from the National Medical Products Administration for its blood purification equipment, models Elix-Ω and Elix-90, valid until July 15, 2031.
Source: